BayCom (BCML) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Net income for Q1 2026 was $8.2 million ($0.75 per diluted share), up 43.5% year-over-year and 19% sequentially, driven by higher net interest income, a reversal of provision for credit losses, and increased noninterest income.
Total assets increased 2.1% to $2.65 billion at March 31, 2026, driven by higher cash and investment securities, partially offset by a decrease in loans.
The company operates a single banking segment, focusing on commercial lending and deposit growth across 34 branches in five states.
Leadership transition announced post-quarter, with new CEO, CFO, and Executive Vice Chair appointed to drive growth and strategic initiatives.
Unusual items, including accretion income, FHLB special dividend, and credit loss reversal, boosted earnings by $0.12 per share.
Financial highlights
Net interest income increased 10.1% year-over-year to $25.2 million, with annualized net interest margin improving to 4.11% from 3.83% year-over-year.
Total loans decreased 2.7% to $2.01 billion, primarily due to repayments outpacing new originations.
Deposits grew 2.3% to $2.27 billion, with noninterest-bearing deposits comprising 26.9% of the total.
Noninterest income increased 74.6% sequentially to $1.5 million, mainly due to equity securities gains and higher loan sale gains.
Noninterest expense rose 2.1% sequentially and 3.2% year-over-year, mainly from higher salaries and benefits.
Outlook and guidance
Management expects a stronger loan pipeline and improved loan demand in the remainder of 2026, following a challenging Q1.
The company remains focused on organic and acquisition-driven growth, maintaining strong capital and liquidity positions.
Leadership transition is intended to support the next phase of growth and expansion in the Western Region.
Management expects minimal future impact from acquired loan accretion and special FHLB dividends.
Latest events from BayCom
- Annual meeting to elect directors, vote on pay, and ratify auditor, with online voting available.BCML
Proxy filing29 Apr 2026 - Annual meeting features leadership transition, board elections, and focus on governance and ESG.BCML
Proxy filing29 Apr 2026 - Q4 2025 earnings grew 37% sequentially on higher net interest income and lower credit loss provisions.BCML
Q4 202522 Jan 2026 - Director elections, say-on-pay, and auditor ratification headline a governance-focused agenda.BCML
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with online proxy access.BCML
Proxy Filing2 Dec 2025 - Earnings declined on higher credit loss provisions, but capital and liquidity remain strong.BCML
Q3 20257 Nov 2025 - Q2 2024 net income fell 22% as margins compressed, but capital and deposits remained strong.BCML
Q2 202414 Oct 2025 - Earnings and net interest margin improved, with robust capital and higher nonperforming loans.BCML
Q2 202511 Aug 2025 - Q3 net loss widened to $16.8M; $182.2M cash on hand supports clinical pipeline into 2027.BCML
Q3 202413 Jun 2025